elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q57172529-4D3B8F08-1F2C-4320-AA92-75776505FE8A
Q57172529-4D3B8F08-1F2C-4320-AA92-75776505FE8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57172529-4D3B8F08-1F2C-4320-AA92-75776505FE8A
Nephrotoxicity of Cancer Immunotherapies: Past, Present and Future
P2860
Q57172529-4D3B8F08-1F2C-4320-AA92-75776505FE8A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57172529-4D3B8F08-1F2C-4320-AA92-75776505FE8A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5b7c91604b3e5bb9fdaae8a519792af8c709f03d
P2860
Chimeric antigen receptor T-cell therapy - assessment and management of toxicities.